Anti N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis with Frustrated Diagnosis Course: A Case Report


Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a rare disease with uncertain etiology and pathogenesis that affects young women. Its diagnosis can be delayed because of the nonspecific neuropsychiatric symptoms in the foreground. This article describes the details of a recent complicated case of a patient with this condition which is related to an ovarian teratoma. Correct diagnostic and prompt treatment of anti-NMDA receptor encephalitis remains a serious clinical challenge due to its unspecific manifestations and varying response to treatments. The information will be of interest to clinicians working with encephalitis patients.

Share and Cite:

Liao, H. , Zhou, H. and Chen, L. (2015) Anti N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis with Frustrated Diagnosis Course: A Case Report. World Journal of Neuroscience, 5, 334-338. doi: 10.4236/wjns.2015.55032.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Tuzun, E. and Dalmau, J. (2007) Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment. Neurologist, 13, 261-271.
[2] Dalmau, J., Tuzun, E., Wu, H.Y., Masjuan, J., Rossi, J.E., Voloschin, A., et al. (2007) Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated with Ovarian Teratoma. Annals of Neurology, 61, 25-36.
[3] Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X.Y., Lai, M.Z., et al. (2008) Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies. The Lancet Neurology, 7, 1091-1098.
[4] Granerod, J., Ambrose, H.E., Davies, N.W., Clewley, J.P., Walsh, A.L., Morgan, D., et al. (2010) Causes of Encephalitis and Differences in their Clinical Presentations in England: A Multicentre, Population-Based Prospective Study. The Lancet Infectious Diseases, 10, 835-844.
[5] Haberlandt, E., Bast, T., Ebner, A., Holthausen, H., Kluger, G., Kravljanac, R., et al. (2011) Limbic Encephalitis in Children and Adolescents. Archives of Disease in Childhood, 96, 186-191.
[6] Asztely, F. and Kumlien, E. (2012) The Diagnosis and Treatment of Limbic Encephalitis. Acta Neurologica Scandinavica, 126, 365-375.
[7] McCoy, B., Akiyama, T., Widjaja, E. and Go, C. (2011) Autoimmune Limbic Encephalitis as an Emerging Pediatric Condition: Case Report and Review of the Literature. Journal of Child Neurology, 26, 218-222.
[8] Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M.R. and Balice-Gordon, R. (2011) Clinical Experience and Laboratory Investigations in Patients with Anti-NMDAR Encephalitis. The Lancet Neurology, 10, 63-74.
[9] Titulaer, M.J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., et al. (2013) Treatment and Prognostic Factors for Long-Term Outcome in Patients with Anti-NMDA Receptor Encephalitis: An Observational Cohort Study. The Lancet Neurology, 12, 157-165.
[10] Hughes, E.G., Peng, X.Y., Gleichman, A.J., Lai, M.Z., Zhou, L., Tsou, R., et al. (2010) Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis. Journal of Neuroscience, 30, 5866-5875.
[11] Posner, J.B. and Dalmau, J. (1995) Clinical Enigmas of Paraneoplastic Neurologic Disorders. Clinical Neurology and Neurosurgery, 97, 61-70.
[12] Vitaliani, R., Mason, W., Ances, B., Zwerdling, T., Jiang, Z.L. and Dalmau, J. (2005) Paraneoplastic Encephalitis, Psychiatric Symptoms, and Hypoventilation in Ovarian Teratoma. Annals of Neurology, 58, 594-604.
[13] Iizuka, T., Sakai, F., Ide, T., Monzen, T., Yoshii, S., Iigaya, M., et al. (2008) Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome without Tumor Removal. Neurology, 70, 504-511.
[14] Lai, M.Z., Hughes, E.G., Peng, X.Y., Zhou, L., Gleichman, A.J., Shu, H., et al. (2009) AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location. Annals of Neurology, 65, 424-434.
[15] Lancaster, E., Lai, M.Z., Peng, X.Y., Hughes, E., Constantinescu, R., Raizer, J., et al. (2010) Antibodies to the GABAB Receptor in Limbic Encephalitis with Seizures: Case Series and Characterisation of the Antigen. The Lancet Neurology, 9, 67-76.
[16] Hachiya, Y., Uruha, A., Kasai-Yoshida, E., Shimoda, K., Satoh-Shirai, I., Kumada, S., et al. (2013) Rituximab Ameliorates Anti-N-Methyl-D-Aspartate Receptor Encephalitis by Removal of Short-Lived Plasmablasts. Journal of Neuroimmunology, 265, 128-130.
[17] Byrne, S., McCoy, B., Lynch, B., Webb, D. and King, M.D. (2014) Does Early Treatment Improve Outcomes in N-Methyl-D-Aspartate Receptor Encephalitis? Developmental Medicine & Child Neurology, 56, 794-796.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.